Brad McGregor, MD | Authors


Combination Therapies Emerge in the Frontline for Renal Cell Carcinoma

April 30, 2018

Brad McGregor, MD, a medical oncologist at Dana-Farber Cancer Institute, discusses the future of combination therapies in the treatment landscape of renal cell carcinoma. He highlights the positive results from a few combinations that have been tested in clinical trials.